Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02690818 · ClinicalTrials.gov registry record · NA
Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02690818 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 30 participants.
The verdict
NCT02690818, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to determine whether regularly scheduled medication reminder text messages (SMS) are effective in increasing latent tuberculosis infection (LTBI) treatment completion.
Interventions
- BEHAVIORAL Regularly scheduled LTBI medication reminder text messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-09-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02690818
The ClinicalTrials.gov registry entry for NCT02690818 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Regularly scheduled LTBI medication reminder text messages is the first listed.
NCT02690818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02690818 about?
NCT02690818 is a clinical study titled "Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging". The purpose of this pilot study is to determine whether regularly scheduled medication reminder text messages (SMS) are effective in increasing latent tuberculosis infection (LTBI) treatment completion.
What is the current status of trial NCT02690818?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-04. Estimated completion is 2018-09-26.
What interventions are being tested in trial NCT02690818?
The interventions under investigation include: Regularly scheduled LTBI medication reminder text messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT02690818?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.